By: dr. B. Devalet
Paroxysmal nocturnal haemoglobinuria (PNH) is a rare hematopoietic stem cell disorder resulting from the somatic mutation of the X-linked PIGA gene. PNH has a very heterogeneous clinical presentation and the treatment for PNH patients depends on the severity of symptoms and the degree of hemolysis. In a special lecture at the 2021 BHS general annual meeting. Dr. Bérangère Devalet and Prof. Nicole Straetmans gave an overview of the current PNH landscape, from diagnosis to management.
* (only possible for healthcare professionals with RIZIV/INAMI/MATRICULE working in the field of Hematology in Belgium and Luxembourg with prescription authorisation)
** (for healthcare professionals with prescribing authorisation working outside the field of Hematology in Belgium and Luxembourg as well as those without prescribing authorisation working as healthcare professional in Hematology in Belgium and Luxembourg, plus persons without prescription authorisation working outside Belgium and Luxembourg, plus healthcare professionals with prescribing authorisation outside Belgium and Luxembourg plus non-healthcare professionals from outside or inside Belgium or Luxembourg)
Top
